| Title |
Date |
| 5-alpha Reductase Inhibitors (5-ARIs) Label Update - Increased Risk of Prostate Cancer |
06/13/2011 |
| Abacavir (Ziagen) and Abacavir-Containing Medications - Patient Screening Recommended |
07/29/2008 |
| Abacavir and Didanosine and Potential Risk of Heart Attack - Ongoing Safety Review - Update |
03/07/2011 |
| Abacavir Sulfate (Ziagen) and Lamivudine/Zidovudine (Combivir) - Third Party Tampering |
4/12/2007 |
| Abbott Blood Glucose Meter Display Problems |
9/13/2007 |
| Abbott Glucose Test Strips - Recall Due to Incorrect Results |
12/23/2010 |
| Able Laboratories Inc. - Recalls All Products/Suspends Manufacturing |
5/25/2005 |
| ACCU-CHEC glucose meter device recall |
1/23/2006 |
| ACCU-CHEK Softclix Lancet Recall |
06/03/2009 |
| Accusure Insulin Syringe Recall - updated |
10/28/2009 |
| Accutane (Isotretinoin) - New Informational FDA web site |
3/29/2007 |
| Accutane and Generic Isotretinoin - iPLEDGE Risk Management Program Modification |
10/12/2006 |
| Accutane and Generic Isotretinoin: New risk management program - iPLEDGE |
8/17/2005 |
| Acetaminophen in Prescription Medications Limited to 325 mg per Dosage Unit |
01/13/2011 |
| Acetaminophen (Tylenol®) Pediatric Liquid Products Recalled Due to Possible Bacterial Contamination - UPDATED |
10/01/2009 |
| Acetaminophen Concentrated Drops - Brookstone Pharmaceuticals Voluntary Recall Due to Packaging Concerns |
07/16/2009 |
| Acetaminophen - FDA Actions to Prevent Overdose |
07/01/2009 |
| Acetaminophen 500 mg Tablets (Store Brands) - Recall |
11/10/2006 |
| Acetylcysteine Injection (Acetadote) - Recall Due to Particulates |
01/03/2011 |
| Actavis Drug Recall |
08/05/2008 |
| Actavis Totowa Digoxin (Digitek®) Recall |
04/29/2008 |
| Actiq lozenges |
9/3/2003 |
| Adacel (DTaP) and Daptacel (Tdap) Administration Errors |
2/2/2007 |
| Adalimumab (Humira) and infections/hypersensitivity/and hematologic reaction |
11/9/2004 |
| Advair Diskus (Fluticasone Propionate and Salmeterol Powder for Inhalation) Stolen - Verify Drug Pedigrees |
07/19/2010 |
| Advanced Medical Optics Recall - Healon D Ophthalmic Viscosurgical Device |
12/12/2008 |
| Advanced Medical Optics Contact Lens Solution Recall |
5/30/2007 |
| Aidapack Services - Recall of Repackaged Products Due To Possible Beta-Lactam Cross Contamination |
06/06/2011 |
| Alaris System Class I Recall |
08/07/2009 |
| Albumin considered safe for use in critically ill patients |
5/20/2005 |
| Albuterol Inhaler (Ventolin HFA) Recalled by GlaxoSmithKline – May Contain Insufficient Propellant |
01/24/2012 |
| Albuterol Sulfate 0.083% Inhalation Solution by Ritedose Corporation - Recall Due to Mislabeled Vials |
01/04/2011 |
| Alcohol-Free Mouthwash - Recall |
05/08/2008 |
| Alcohol Prep Pads, Swabs, and Swabsticks - Recall Due to Possible Microbial Contamination - Update |
02/17/2011 |
| Alefacept (Amevive) not recommended for HIV patients |
11/15/2005 |
| Alemtuzumab (Campath) Associated with Severe Idiopathic Thrombocytopenic Purpura in Multiple Sclerosis Trials |
12/2/2005 |
| Alglucosidase Alfa (Myozyme) - Formation of Black Particles During Reconstitution |
4/12/2007 |
| Alka-Seltzer Plus Day & Night Cold Formula - Recall of a Single Lot by Bayer Consumer Care |
12/09/2009 |
| Altocor® (lovastatin extended release) withdrawal/replaced by Altoprev® |
8/11/2004 |
| Amantadine (Symmetrel, generic) and Rimantadine (Flumadine, generic) - High Levels of Resistance By Influenza A H3N2 Viruses |
1/19/2006 |
| Amicar (aminocaproic acid) and Omacor (omega-3-acid ethyl esters) Dispensing Errors |
3/2/2006 |
| Amiodarone hydrochloride tablets (Cordarone®/generic) - Patient Medication Guide Requirement |
1/13/2005 |
| Ammonul (sodium phenylacetate and sodium benzoate) Injection - Filter Required |
09/25/2008 |
| Amphetamine/Dextroamphetamine (Adderall/Adderall XR)associated with sudden death/sales suspended on Canadian market |
2/10/2005 |
| Anagrelide (Agrylin) exposure increased in patients with hepatic impairment/contraindicated in severe hepatic impairment |
2/10/2005 |
| Anesthetic Agents for Cosmetic Procedures/Topical - Potentially Fatal Adverse Effects |
2/12/2007 |
| Angiotensin Receptor Blockers and Safety Review for Cancer Risk - UPDATE |
06/03/2011 |
| Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors) Associated with Birth Defects in First Trimester |
6/9/2006 |
| Antidepressants and Suicidality in Young Adults |
5/7/2007 |
| Antidepressants and Suicidality in Adults to be Evaluated |
7/1/2005 |
| Antidepressant labeling changes |
7/6/2004 |
| Antidepressants and suicidality in children: FDA requests labeling change |
10/15/2004 |
| Antiepileptic Drugs and Increased Risk of Suicidal Behavior or Suicidal Ideation |
05/06/2009 |
| Antipsychotic Class Labeling Update: Pregnancy Sections Revised to Include Risk of Extrapyramidal Signs and Withdrawal Symptoms in Newborns |
02/23/2011 |
| Antipsychotics (Conventional and Atypical) - Increased Risk of Death in Elderly Patients Taking Antipsychotics for Dementia-Related Psychosis |
06/16/2008 |
| Anti-Tumor Necrosis Factor (TNF) Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], infliximab [Remicade], golimumab [Simponi]), azathioprine, and mercaptopurine - Reports of Hepatosplenic T-Cell Lymphoma - UPDATE |
11/04/2011 |
| Anti-Tumor Necrosis Factor (TNF) Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], infliximab [Remicade], golimumab [Simponi]) -Ongoing Safety Review of Malignancy Risk - UPDATE |
11/04/2011 |
| Aprotinin (Trasylol) Marketing Temporarily Suspended Pending Ongoing Safety Review - Update |
11/5/2007 |
| Aprotinin (Trasylol): Increased Risk Of Myocardial Infarction/Stroke/Renal Dysfunction/and Anaphylaxis - Update |
12/18/2006 |
| Aranesp (darbepoetin alfa) and Adverse Effects with Off-Label Dosing |
1/14/2005 |
| Arava (leflunomide) |
11/21/2003 |
| Argatroban Injection 50 mg/50mL - Voluntary Recall Due To Particulate Matter |
12/06/2011 |
| Aromatase Inhibitors, Recall of Dietary Supplement Products Containing |
09/20/2010 |
| Asenapine and Serious Hypersensitivity Reactions |
09/02/2011 |
| Aspirin and Ibuprofen Drug Interaction |
9/14/2006 |
| Astellas Recall of Lots of Several Medications Due to Stolen Transport Trailer |
07/23/2009 |
| Atomoxetine (Strattera) - Increased Risk of Suicidal Ideation in Pediatric Patients |
10/2/2005 |
| Atomoxetine (Strattera) associated with liver toxicity |
12/22/2004 |
| Atypical Antipsychotics - increased mortality in elderly patients with dementia |
4/12/2005 |
| Atypical antipsychotics and hyperglycemia |
9/1/2004 |
| Avastin® (bevacizumab) - FDA Proposes Removal of Breast Cancer Indication |
12/20/2010 |
| Avian Flu Therapies/Fraudulent |
1/3/2006 |
| Avastin (Bevacizumab) and Tracheoesophageal Fistula |
4/24/2007 |
| Avastin (bevacizumab) increased risk of arterial thromboembolic events - Update |
1/5/2005 |
| Baby's Bliss Gripe Water by MOM Enterprises Recalled |
9/28/2007 |
| Bacteriostatic Sodium Chloride Injection 0.9% from American Regent - Recall Due to Particulates |
03/21/2011 |
| Balanced Salt Solution by Cytosol Labs Recalled |
2/15/2006 |
| Belatacept (Nulojix): REMS Required Due to Post-Transplant Lymphoproliferative Disorder and Progressive Multifocal Leukoencephalopathy |
07/08/2011 |
| Becaplermin Gel (Regranex) and Risk of Cancer Death - Ongoing Safety Review |
06/10/2008 |
| Bedford Laboratories Recall: Polymyxin B and Vecuronium |
01/12/2012 |
| Benadryl Extra Strength Itch Stopping Gel - "For Skin Use Only" Added to Prominent Areas of the Product |
05/14/2010 |
| Bendamustine Hydrochloride (Treanda®) Recall – Particulate Matter in Vial |
01/30/2012 |
| Benzocaine Sprays, Gels and Liquids: Increased Risk of Methemoglobinemia - Update |
04/08/2011 |
| Benzonatate (Tessalon) - Potential for Accidental Overdose by Children |
12/14/2010 |
| Benzoyl Peroxide 10% Topical Acne Gel - Product Recall |
11/18/2008 |
| Bevacizumab (Avastin) - FDA Removes Breast Cancer Indication - Update |
11/21/2011 |
| Bevacizumab (Avastin®) Repackaged Intravitreal Injections - Risk of Serious Infections |
09/01/2011 |
| Bevacizumab (Avastin®) and sunitinib (Sutent®) – combined use may increase risk of microangiopathic hemolytic anemia |
07/14/2008 |
| Bevacizumab (Avastin) and Tracheoesophageal Fistula |
4/24/2007 |
| Bevacizumab (Avastin®) and Risk of Reversible Posterior Leukoencephalopathy Syndrome (RPLS) and Nasal Septum Perforation |
9/27/2006 |
| Bioidentical Hormone Replacement Therapy - Misleading Information |
01/11/2008 |
| Bismacine Injection (Chromacine) - Avoid Use for Lyme Disease |
7/25/2006 |
| Bisphosphonates - Update of Safety Review of FDA Early Communication Regarding Atrial Fibrillation |
11/13/2008 |
| Bisphosphonates (alendronate [Fosamax, Fosamax plus D], etidronate [Didronel], ibandronate [Boniva], pamidronate [Aredia], risedronate [Actonel, Actonel and calcium], tiludronate [Skelid], zoledronic acid [Reclast, Zometa]) - Bone, Joint, and Musculoskeletal Pain Reminder |
01/07/2008 |
| Bisphosphonate-Induced Renal Dysfunction in Oncology Practice |
3/10/2005 |
| Blood Glucose Test Strip Recall - OneTouch® SureStep® Test Strips |
03/02/2010 |
| Body Building Products Containing Unapproved Synthetic Steroids - FDA Issues Warning |
01/19/2010 |
| Bortezomib (Velcade) - Dose Adjustment in Hepatic Impairment |
01/27/2010 |
| Bosentan (Tracleer) 5/Cause Hepatotoxicity |
3/3/2006 |
| Botulinum Toxin Types A (Botox, Botox Cosmetic, Dysport) and Botulinum Toxin Type B (Myobloc) - Safety Review Update and Names Changed to OnabotulinumtoxinA (Botox, Botox Cosmetic), AbobotulinumtoxinA (Dysport), and RimabotulinumtoxinB (Myobloc) |
08/04/2009 |
| Brazilian Diet Pills 5/Contain Chlordiazepoxide/Fluoxetine/or Stimulants |
1/19/2006 |
| Brentuximab Vedotin (Adcetris) – New Warnings About Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity |
01/17/12 |
| Butalbital / Acetaminophen / Caffeine Tablets and Hydrocodone / Acetaminophen Tablets from Qualitest - Recall Due To Potential Mislabeling |
06/27/2011 |
| Bupropion (Zyban and generics) - Neuropsychiatric Events and Suicidality Warnings added to the Prescribing Information - Update |
07/06/2009 |
| Caffeine Citrate Powder/Purified - Recall |
5/22/2007 |
| Calcilo XD Infant Formula - Product Recall |
06/04/2008 |
| Caraco Medications Seized by US Marshals Due to Ongoing Quality Problems UPDATED |
06/30/2009 |
| Carbamazepine (Tegretol) - Skin Reactions More Common in Patients with Human Leukocyte Antigen B*1502 Allele |
12/12/2007 |
| Cefepime (Maxipime) - Ongoing Safety Review |
06/18/2009 |
| Ceftriaxone Injection (Rocephin) - Interaction with Calcium Products and New Contraindication in Hyperbilirubinemic Neonates — UPDATE |
04/14/2009 |
| Celecoxib (Celebrex) cardiovascular risk |
12/21/2004 |
| Celestone® (Betamethasone) Oral Solution Due to Dosing Variability, Merck Recalls |
01/30/2012 |
| cetirizine HCl/Name confusion with |
2/10/2005 |
| Cetuximab (Erbitux) - Additional Monitoring for Electrolyte Abnormalities and Infusion Reactions |
9/15/2005 |
| Changes to CII prescribing - Postdating no longer allowed |
3/23/2005 |
| Chelated Over-the-Counter (OTC) Products - FDA Warns Against Use |
10/18/2010 |
| Children's Tylenol Meltaways 80 mg/Children's Tylenol SoftChews 80 mg/and Junior Tylenol Meltaways 160 mg - recalled due to confusing packaging and labeling |
6/6/2005 |
| Chiron's Influenza Virus Vaccine (Fluvirin) Delayed/Shipment of |
9/2/2004 |
| Chondrolysis Associated with Continuously Infused Local Anesthetics [bupivacaine (Marcaine; Sensorcaine); chloroprocaine (Nesacaine); lidocaine (Xylocaine); mepivacaine (Carbocaine; Polocaine); procaine (Novocain); ropivacaine (Naropin)] |
11/17/2009 |
| Citalopram hydrobromide (Celexa) and Abnormal Heart Rhythms: New Labeling Changes |
08/24/2011 |
| Citalopram and Finasteride by Greenstone - Recalled due to Mislabeling |
03/29/2011 |
| Clarcon Hand Sanitizers and Skin Protectants Recall |
06/11/2009 |
| Clarithromycin (Biaxin/Biaxin XL)- study shows increased cardiovascular mortality |
12/13/2005 |
| Clevidipine Butyrate Injection (Cleviprex) - Recall |
03/19/2010 |
| Clindamycin Injection - APP Pharmaceuticals Recalls 11 Lots |
02/05/2010 |
| Clopidogrel Bisulfate (Plavix) -Box Warning on Poor Metabolizers |
03/15/2010 |
| Clopidogrel Bisulfate (Plavix) - Potential Interactions with Omeprazole (Prilosec) and Esomeprazole (Nexium) - Ongoing Safety Review - UPDATE |
11/19/2010 |
| Chlorhexidine Gluconate Skin Preparation Cloth - Recall |
07/02/2008 |
| Clozapine (Clozaril, generic) Labeling Changes - White Blood Cell Count Monitoring Changes |
1/13/2006 |
| Cochlear Implant Device Increases Risk of Pneumococcal Meningitis - Immunization Recommended |
10/17/2007 |
| Codeine use in Nursing Mothers with a Specific CYP2D6 Genotype may lead to Morphine Overdose in the Nursing Infant |
8/17/2007 |
| Colchicine Products, FDA Bans the Manufacture of Unapproved Injectable |
02/06/2008 |
| Colchicine Injection - Recall of Compounded Product |
5/3/2007 |
| Colistimethate Injection- Risk of Serious or Fatal Dosing Errors |
07/14/2011 |
| Colistimethate (Coly-Mycin M®, generics) Inhalation Possibly Associated With Death |
7/2/2007 |
| Combivir (Lamivudine/Zidovudine) and Ziagen (Abacavir Sulfate) - Third Party Tampering |
4/12/2007 |
| Compounded Inhalation Solutions 5/Not Be Safe, Unapproved |
8/11/2006 |
| Compounding Topical Anesthetic Creams and Other Products/FDA Warns Pharmacies Against |
09/25/2009 |
| Concentrated Sodium Chloride Injection 23.4% from American Regent - Recall Due to Particulates |
03/21/2011 |
| Contact Lens Solutions: Fungal Eye Infections in Soft Contact Lens Wearers |
4/14/2006 |
| Corvalol - Unapproved Drug Contains Phenobarbital |
11/21/2008 |
| Cough and Cold Medications Update - Infant Deaths and Use in Children — UPDATED |
10/10/2008 |
| Counterfeit Medications on the Internet - FDA Warning about Orlistat (Xenical) |
5/3/2007 |
| COX-2 Selective Inhibitors and NSAIDs - Patient Medication Guide Requirement |
6/16/2005 |
| Creon - Newly Approved Formulation Requires New Prescription |
07/06/2009 |
| Cyclopentolate and Tropicamide Administration Errors |
06/27/2008 |
| Dabigatran etexilate mesylate (Pradaxa®) – Ongoing Safety Review of Post-Marketing Reports Related to Serious Bleeding Events |
12/07/2011 |
| Dabigatran (Pradaxa®) - Important Storage and Handling Requirements |
11/09/2011 |
| Daptacel (DTaP) and Adacel (Tdap) Administration Errors |
2/2/2007 |
| Daptomycin (Cubicin) - Risk of Eosinophilic Pneumonia |
07/29/2010 |
| Daptomycin (Cubicin) - MBT Contaminant When Stored in ReadyMED Elastomeric Pump |
04/10/2008 |
| Darbepoetin alfa [Aranesp]/Erythropoiesis-Stimulating Agent Increases Death in Non-Chemotherapy-Induced Anemia |
2/20/2007 |
| Darbepoetin alfa/Epoetin alfa: Hemoglobin Target above 12 g/dL Increases Cardiovascular Risk |
11/20/2006 |
| Darunavir (Prezista)- Hepatotoxicity Warnings |
3/14/2008 |
| Dasatinib (Sprycel) May Increase Risk of Pulmonary Arterial Hypertension |
10/12/2011 |
| Daytrana (Methylphenidate) Patch - Recall of Specific Lots by Shire Pharmaceuticals |
02/03/2010 |
| Daytrana™ (Methylphenidate Transdermal System) Recall |
9/7/2007 |
| DEA Numbers 5/Begin With Letter "F" |
10/16/2006 |
| Deferasirox (Exjade) - New Boxed Warning about Potentially Fatal Renal, Hepatic, Hematologic, and Allergic Events |
02/23/2010 |
| Deferasirox (Exjade) - Potentially Fatal Renal, Hepatic, Hematologic, and Allergic Events |
5/23/2007 |
| Denileukin diftitox (Ontak) 5/Cause Visual Loss |
3/17/2006 |
| Desipramine (Norpramin®) - New Warnings in Patients with a Family History of Cardiac Disorders |
12/03/2009 |
| Desmopressin - Risk of Hyponatremia and Seizures |
12/06/2007 |
| Dexamethasone Sodium Phosphate 4 mg/mL Injection from American Regent - Recall Due to Particulates |
03/21/2011 |
| Dexamethasone Sodium Phosphate Injection, 4 mg/mL, 30 mL Multiple Dose Vials Recalled - Particulates in Product |
12/28/2010 |
| Dexlansoprazole (Kapidex) - Brand Name Change, Confusion with Casodex and Kadian |
03/05/2010 |
| Dextroamphetamine/Amphetamine 20 mg Tablet Recall by Barr |
08/18/2009 |
| Dextroamphetamine sulfate 5 mg tablets by Ethex recall |
10/17/2008 |
| Dextroamphetamine (Dexedrine/Dexedrine Spansule) Labeling Changes/Including Sudden Death |
2/23/2007 |
| Dextromethorphan abuse associated with death |
5/25/2005 |
| Diazepam Rectal Gel (Diastat Acudial): Applicator Defect 5/Prevent Delivery of Complete Dose. |
3/31/2006 |
| Diclofenac Topical Gel 1% (Voltaren Gel) and Hepatic Toxicity |
12/07/2009 |
| Didanosine (Videx, Videx EC) and Non-Cirrhotic Portal Hypertension |
02/01/2010 |
| Digoxin Tablet Recall by Caraco - UPDATED |
05/13/2009 |
| Disposal of Prescription Medications in the Community - Federal Guidelines |
09/06/2011 |
| Dolasetron Safety Announcement |
12/17/2010 |
| Dolasetron (Anzemet) |
2/3/2003 |
| Doxazosin 4 mg Extended Release Tablets (Cardura XL) Recalled by Pfizer for Irregular 8-hour Dissolution Result |
01/24/2012 |
| Dronedarone (Multaq®) – Two-fold Increased Risk of Death and Serious Adverse Events – Update |
12/22/2011 |
| Dronedarone (Multaq): Potential for Severe Liver Injury |
01/19/2011 |
| droperidol (Inapsine) |
1/19/2002 |
| Drospirenone-Containing Birth Control Pills - Ongoing Safety Review for Increased Risk of Venous Thromboembolic Events |
06/01/2011 |
| Drotrecogin alfa (Xigris) - Withdrawn From Worldwide Market |
10/25/2011 |
| Drotrecogin alfa [activated] (Xigris) - Ongoing Safety Review |
02/05/2009 |
| Drotrecogin alfa (Xigris) Not Effective in Pediatric Patients with Severe Sepsis |
04/29/2005 |
| Dulcolax Products - not all formulations contain bisacodyl |
4/27/2004 |
| Duloxetine (Cymbalta®) 5/Exacerbate Hepatic Injury in Patients with Preexisting Liver Disease |
10/18/2005 |
| Duragesic Patch Recall UPDATE |
4/6/2004 |
| Duragesic Patch Recall |
2/23/2004 |
| Ear Candles - Risk of Serious Injuries, Avoid Use |
02/23/2010 |
| Edetate Disodium - Sound-Alike Confusion with Edetate Calcium Disodium |
01/22/2008 |
| Efalizumab (Raptiva®) withdrawal |
04/13/2009 |
| Efalizumab (Raptiva) and Progressive Multifocal Leukoencephalopathy (Update) |
02/20/2009 |
| Efalizumab (Raptiva) associated with hemolytic anemia/thrombocytopenia/and serious infection |
7/20/2005 |
| Efavirenz (Sustiva) - Pregnancy Risk has Changed to Category D (positive evidence of fetal risk). |
6/13/2005 |
| Electronic Cigarette - A Potential Health Hazard |
07/28/2009 |
| Eltrombopag (Promacta®) - Portal Venous System Thromboses in Patients with Chronic Liver Disease |
05/14/2010 |
| Enoxaparin (Lovenox) adjust dose for severe renal impairment |
8/17/2004 |
| Entacapone/carbidopa/levodopa (Stalevo): Ongoing Cardiovascular Safety Review |
08/23/2010 |
| Entacapone/carbidopa/levodopa (Stalevo): Ongoing Prostate Cancer Safety Review |
04/05/2010 |
| Entecavir (Baraclude) and Possible HIV Resistance — UPDATED |
8/20/2007 |
| Ephedra |
12/30/2003 |
| Ephedrine alkaloids in dietary supplements illegal to market in US |
9/7/2006 |
| Epoetin alfa, Darbepoetin alfa: New Risk Management Program |
03/25/2010 |
| Epoetin alfa/Darbepoetin alfa: Hemoglobin Target above 12 g/dL Increases Cardiovascular Risk |
11/20/2006 |
| Epoetin alfa (Eprex) in the Treatment of Acute Ischemic Stroke |
09/30/2008 |
| Epoetin Alfa (Epogen®/Procrit®) and Darbepoetin Alfa (Aranesph®) - Associated with Pure Red Cell Aplasia |
12/2/2005 |
| Epogen® and Procrit® (Epoetin Alfa) - Recall |
09/29/2010 |
| Erectile Dysfunction Dietary Supplements - Dangerous Ingredients — UPDATED |
03/29/2011 |
| Erectile Dysfunction Drugs and Vision Loss |
7/12/2005 |
| Ergotamine – FDA Halts Marketing of Unapproved Products |
3/5/2007 |
| Eribulin (Halaven) and Epirubicin (Ellence, generic) Name Confusion |
01/17/2012 |
| Erlotinib (Tarceva) and New Safety Information |
05/11/2009 |
| Erlotinib (Tarceva) and Hepatic Dysfunction |
09/24/2008 |
| Ertapenem Sodium (Invanz) Recall |
7/9/2007 |
| Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Erythropoietin alfa [Epogen, Procrit]) - Proposed Changes in Product Labeling for Kidney Disease |
06/27/2011 |
| Etravirine (Intelence™): Severe Skin and Hypersensitivity Reactions |
09/03/2009 |
| Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Erythropoietin alfa [Epogen, Procrit]) - Proposed Changes in Product Labeling |
08/07/2009 |
| Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Epoetin alfa [Epogen, Procrit]) - Revised Black Box Warnings - UPDATED |
03/14/2008 |
| Estradiol Transdermal Spray (Evamist): Unintended Exposure by Children and Pets |
07/30/2010 |
| Etanercept (Enbrel) Black Box Warning of Infection Risk— UPDATED |
05/02/2008 |
| Ethex Recalls Additional Products More Than 60 Drug Products-Updated |
02/10/2009 |
| Exenatide (Byetta®) - Altered Kidney Function Reported |
11/03/2009 |
| Exenatide (Byetta) and Pancreatitis— UPDATED |
08/20/2008 |
| Extenze Dietary Supplement Recall of 2 Lots - Counterfeit Lots Contain Undeclared Ingredients |
02/24/2011 |
| Ezetimibe/Simvastatin versus Simvastatin Alone (ENHANCE) - Update of Ongoing Data Review |
01/12/2009 |
| Famotidine and Lorazepam Administration Errors |
9/7/2006 |
| Fentanyl Boxed Warnings |
7/12/2005 |
| Fentanyl Buccal Tablet (Fentora®) - Inappropriate Use Causes Death/Adverse Effects— UPDATED |
9/28/2007 |
| Fentanyl 25 mcg/hr Patch from Actavis - Recall |
10/22/2010 |
| Fentanyl Transmucosal Products (Abstral, Actiq, Fentora, Lazanda, Onsolis; generics) – New Class-Wide Risk Management Program |
12/30/2011 |
| Fentanyl Transdermal System Recall (Actavis, Abrika) |
03/04/2008 |
| Fentanyl 50 mcg/hour Transdermal System Recall (Duragesic - Janssen, generic - Sandoz) |
01/02/2009 |
| Fentanyl 25 mcg/hour Transdermal System Recall (Duragesic - Janssen, generic - Sandoz) |
02/19/2008 |
| Fentanyl Transdermal Patch (Duragesic, generics) - Cautions About Safe and Appropriate Use |
12/24/2007 |
| FDA Removes Unapproved Cough, Cold, and Allergy Products from U.S. Market |
03/02/2011 |
| Fingolimod (Gilenya) and Risk of Death – Ongoing Safety Review |
12/20/2011 |
| Floranex (Lactobacillus) and Florinef (fludrocortisone) Name Confusion |
1/2/2007 |
| Flu Vaccine Update - Keep Vaccinating |
02/20/2009 |
| Fluconazole (Diflucan®): Chronic, High-Dose Therapy May be Associated with Birth Defects |
08/04/2011 |
| Fluoroquinolones Boxed Warning: Myasthenia Gravis |
03/23/2011 |
| Fluoroquinolones and Tendinitis and Tendon Rupture |
07/09/2008 |
| Flutamide Capsules due to Potential Presence of Imatinib Mesylate Capsule, Teva Recalls |
01/30/2012 |
| Fluvirin (Influenza Virus Vaccine) Recall |
12/27/2010 |
| Formoterol Fumarate (Foradil) and Tiotropium Bromide (Spiriva) Capsules, Correct Use of |
03/04/2008 |
| Formula (Infant) with Iron Recall - Abbott Similac Special Care 24 Cal/fl. oz. Ready-to-Feed Premature |
5/30/2007 |
| Fortovase/Invirase (Saquinavir) plus Ritonavir (ritonavir boosted saquinavir) interacts with rifampin - increased liver toxicity reported |
2/10/2005 |
| Fosamprenavir (Lexiva) - Increased Risk of Myocardial Infarction and Dyslipidemia |
12/04/2009 |
| Fosphenytoin Sodium Injection from Hospira- Recall |
05/27/2010 |
| Gabapentin 100 mg capsules (Neurontin) - Recall |
3/22/2005 |
| Gadolinium-Containing Contrast Agents (Omniscan®, OptiMARK®, Magnevist®, Eovist ®, Ablavar®, ProHance®, MultiHance®) and Serious Nephrogenic Fibroses - Update |
9/10/2010 |
| Galactose, Maltose, and Xylose Products May Falsely Elevate Glucose Results - Update |
08/24/2011 |
| Galantamine brand name changed to Razadyne |
4/25/2005 |
| Galantamine (Reminyl) - possible increased mortality in patients with mild cognitive impairment |
4/5/2005 |
| GammaGard Liquid Recall |
06/07/2010 |
| Gatifloxacin (Tequin) and Blood Glucose Abnormalities/Contraindicated in Diabetics |
2/17/2006 |
| Gefitinib (Iressa) - shows no survival benefit for non-small cell lung cancer/use discouraged. |
6/17/2005 |
| Gemtuzumab Market Withdrawal |
06/23/2010 |
| GenTeal Gel and GenTeal GelDrops Artificial Tears Recall (Novartis Ophthalmics) |
11/23/2005 |
| Gentlease Infant Formula Recalled |
2/24/2006 |
| Genzyme Products including alglucosidase alfa (Myozyme), algasidase beta (Fabrazyme), imiglucerase (Cerezyme), laronidase (Aldurazyme), and thyrotropin alfa (Thyrogen) - Possible Particulate Matter Contamination |
11/16/2009 |
| Goldline Brand Extra-Strength Acetaminophen 500 mg (Genapap/Genebs)/Recall of |
5/5/2006 |
| Golimumab (Simponi) Injection - Recall Due to Malfunctioning Autoinjector |
02/22/2011 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists - Diabetes and Cardiovascular Risk with Goserelin (Zoladex), Histrelin (Vantas), Leuprolide (Eligard, Lupron, Viadur), Nafarelin (Synarel), and Triptorelin (Trelstar) - Update |
10/21/2010 |
| Gotu Kola (Centella asiatica) and Bladderwrack (Fucus vesiculosus) Dietary Supplement Recall – Potential Salmonella Contamination |
12/23/2011 |
| Granisetron (Kytril) |
2/3/2003 |
| Griseofulvin (Grifulvin V) Oral Suspension - Recall |
4/12/2007 |
| Guaifenesin Over-The-Counter Tablets - Recall Due to Mislabeling |
12/13/2010 |
| Guillain Barre Syndrome associated with meningococcal conjugate vaccine |
10/4/2005 |
| H1N1 Monovalent Vaccine Live 2009 (Intranasal) -Revised Expiration Dating |
01/15/2010 |
| Haloperidol - Updated Labeling Regarding Risk of Torsades de Pointes and QT Prolongation |
9/19/2007 |
| Heparin: Change in Reference Standard- New Universal Standardization in Heparin Potency |
04/08/2010 |
| Heparin Administration Errors - Use of Incorrect Concentrations |
2/12/2007 |
| Heparin Lock Flush Pre-filled Syringes and Normal Saline Pre-filled Flush Syringes Recalled by AM2 PAT, Inc. - Update |
01/23/2008 |
| Heparin -Induced Thrombocytopenia - Delayed-Onset Warning |
12/12/2006 |
| Heparin Sodium - Voluntary Recall of 7 lots of B. Braun Heparin Products |
11/02/2010 |
| Heparin - Voluntary Recall of All Baxter Heparin Vials, B. Braun Heparin Large Volume Infusion Bags, and Covidien (Kendall) Heparin Flush Prefilled Syringes - Update |
06/18/2008 |
| Hepatitis B Vaccine Products Stocked in the Pharmacy |
9/6/2005 |
| HMG-CoA-reductase inhibitors do not increase incidence of amyotrophic lateral sclerosis (AML) |
09/30/2008 |
| hormone replacement therapy update |
4/16/2004 |
| Hospira Recall - Potassium 20 mEq in 5% Dextrose/ 0.45% Sodium Chloride |
12/09/2008 |
| Hospira recall of Sodium Chloride 0.9% and Lidocaine 0.4% in Dextrose 5% |
01/25/2012 |
| Human Growth Hormone, Recombinant (somatropin) - FDA Review for Increased Risk of Death |
12/23/2010 |
| Human Papillomavirus Recombinant Quadrivalent Vaccine, Types 6, 11, 16, 18 (Gardasil®) -Safety Update |
07/25/2008 |
| Human rabies vaccine (Imovax - Aventis Pasteur) |
4/6/2004 |
| Hydralazine HCl 20mg/mL Injection - Recall |
8/18/2006 |
| Hydrocodone with Acetaminophen Tablets and Phenobarbital Tablets (Qualitest Pharmaceuticals) - Recall Due to Incorrect Labeling |
02/08/2011 |
| Hydrocodone Long-Acting Antitussives (Tussionex) - Safe Use |
04/24/2008 |
| Hydrocodone Antitussives - FDA Halts Marketing of Unapproved Products |
9/28/2007 |
| Hydromorphone 2 mg Tablet Recall by Ethex |
12/24/2008 |
| Hydromorphone Extended Release (Palladone) withdrawn for safety reasons |
7/14/2005 |
| Hydroxyurea (Droxia, Hydrea, generic) Associated Cutaneous Vasculitic Toxicities |
1/26/2006 |
| Hyland's Teething Tablets Recalled - Potential Risk of Harm to Children |
10/25/2010 |
| Hylenex Injection from Baxter Healthcare - Recall |
05/27/2010 |
| Hyperactivity Medications: Patient Medication Guide Required due to Cardiovascular and Psychiatric Adverse Effects |
2/23/2007 |
| Ibritumomab tiuxetan (Zevalin) and Rituximab (Rituxan) - Potentially-fatal Skin and Mucus Membrane Reactions |
11/3/2005 |
| Ibuprofen and Aspirin Drug Interaction |
9/14/2006 |
| Ibuprofen topical OTC formulations marketed unlawfully - Warning letters issued by the FDA |
08/26/2009 |
| Icy Hot Heat Therapy Products - Recall |
02/12/2008 |
| Imatinib Mesylate (Gleevec®) - Cardiac Events |
10/19/2006 |
| Immune Globulin (GamaSTAN S/D™) - Uncalibrated Syringes |
03/06/2008 |
| Immunosuppressant Drugs - Labeling Changes Warning of Increased Risk of Opportunistic Infections |
07/15/2009 |
| Indomethacin for Injection by Bedford - Voluntary Recall of a Single Lot |
06/16/2011 |
| Infant Acetaminophen Concentration Available, New – Use Caution to Avoid Dosing Errors |
12/23/2011 |
| Infants' Mylicon Gas Relief Dye Free Drops Recall |
11/13/2008 |
| Infant Formula by Gentlease Recalled |
2/24/2006 |
| Infliximab (Remicade) associated with hepatotoxicity |
12/22/2004 |
| Infliximab (Remicade) new hematologic side effects warnings |
8/25/2004 |
| Influenza Virus Vaccine (Afluria®) - Risk of Febrile Events |
08/02/2010 |
| Inhaled Insulin (Exubera) and Lung Cancer |
04/10/2008 |
| Insulin Pens and Cartridges - Risk of Blood-Borne Disease Transmission with Shared Use |
03/20/2009 |
| Insulin Syringe (ReliOn) Recall |
11/07/2008 |
| Interferon Gamma-1b (Actimmune) - Early Termination of Trial for Idiopathic Pulmonary Fibrosis |
3/9/2007 |
| (IGIV) Intravenous Immune Globulin |
5/20/2002 |
| Ipilimumab (Yervoy) and Serious Immune Mediated Adverse Reactions |
04/07/2011 |
| Insulin Detemir (Levemir) - Stolen Vials Resurface, Product Potentially Defective |
08/26/2009 |
| Insulin Glargine (Lantus) - Risk of Cancer |
07/01/2009 |
| Insulin Products/Eli Lilly Discontinuing Humulin U Ultralente/Humulin L Lente/Regular Iletin II/and NPH Iletin II |
7/7/2005 |
| Interferon Alfa-2b (Intron A) Injection Pens - Recall of Several Lots by Schering-Plough |
11/11/2009 |
| Interferon beta-1b (Betaseron) 5/cause hepatotoxicity |
4/25/2005 |
| Interferon beta-1a (Avonex) - Reports of serious hepatic injury |
3/17/2005 |
| Intravenous Ciprofloxacin, Metronidazole, and Ondansetron Injection Made by Claris Lifesciences - Recall |
06/01/2010 |
| Iopromide 370 mg/mL Injection (Ultravist) Recall |
7/25/2006 |
| Irinotecan Hydrochloride Injection - Recall Due to Fungal Contamination |
03/28/2011 |
| Iron dextran injection (Dexferrum) - Black Box Warning for Potentially Fatal Anaphylactic Reaction |
10/20/2009 |
| Isotretinoin (Accutane, generic) - New Informational FDA web site |
3/29/2007 |
| Kaopectate - Reformulation |
8/2 /2005 |
| Ketamine HCl (Ketalar) 10mg/mL Injection - Recall |
12/14/2006 |
| Ketorolac Tromethamine Injection - Voluntary Recall |
10/22/2009 |
| KV Pharmaceutical Tablet Shipment Suspension |
12/24/2008 |
| Lamictal (Lamotrigine) and Lamisil (Terbinafine) Name Confusion |
8/7/2006 |
| Lamisil (Terbinafine) and Lamictal (Lamotrigine) Name Confusion |
8/7/2006 |
| Lamivudine/Zidovudine (Combivir) and Abacavir Sulfate (Ziagen) - Third Party Tampering |
4/12/2007 |
| Lamivudine/Abacavir and Tenofovir | 7/31/2003 |
| Lamotrigine (Lamictal) and Aseptic Meningitis |
08/13/2010 |
| Lamotrigine (Lamictal) During Pregnancy 5/Increase Risk of Cleft Lip or Cleft Palate |
10/3/2006 |
| Lansoprazole Delayed-Release Orally Disintegrating Tablets from Teva - Withdrawn for Clogging Oral Syringes and Feeding Tubes |
04/15/2011 |
| Lantus (insulin glargine [rDNA origin] injection recall Lot 40D024/Lot 40D025/Lot 40D027) |
8/19/2004 |
| Leflunomide (Arava) and Risk of Severe Liver Injury |
07/14/2010 |
| Lenalidomide (Revlimid): Ongoing Safety Review for Increased Malignancy Risk |
04/11/2011 |
| Levoxyl (levothyroxine) |
10/6/2004 |
| Linezolid (Zyvox®) - Increased Mortality Following Treatment of Intravascular Catheter-Related Infections |
3/19/2007 |
| Linezolid (Zyvox) - Intravenous injection transitioning to Freeflex® IV bag |
02/22/2011 |
| Liposyn II and Liposyn III (Hospira) - Recall of Additional Lots Due to Presence of Particulate Matter - UPDATE |
06/11/2010 |
| Liraglutide [rDNA origin] (Victoza)- Risk of Acute Pancreatitis and Thyroid C-cell Tumors |
06/14/2011 |
| Live Oral Pentavalent Rotavirus Vaccine (RotaTeq) - Post-Marketing Reports of Intussusception |
2/20/2007 |
| Live Oral Pentavalent Rotavirus Vaccine (RotaTeq) - Reports of Kawasaki Disease |
6/19/2007 |
| Long-Acting Beta-2 agonists (Formoterol [Foradil Aerolizer], Formoterol/Fluticasone [Symbicort], Salmeterol [Serevent Diskus], Salmeterol/Fluticasone [Advair Diskus, Advair HFA]) - New Requirements for Use in Asthma |
02/23/2010 |
| Long-Acting Beta 2-Agonists Can Increase Severe Asthma Episodes | 11/18/2005 |
| Lopinavir/Ritonavir (Kaletra) Oral Solution - Warning Added to Label: Risk of Serious Adverse Events in Premature Babies |
03/09/2011 |
| Lopinavir/Ritonavir Oral Solution (Kaletra) - Potential Risk of Overdose in Children |
8/15/2007 |
| Lorazepam and Famotidine Administration Errors |
9/7/2006 |
| Maalox Brand Products and Potential for Medication Errors |
02/18/2010 |
| Magnesium Sulfate and Potassium Phosphate - Potential for Error |
08/06/2009 |
| MBI Ordered to Cease Manufacturing and Distributing Products |
12/2/2005 |
| McNeil Consumer Healthcare Recall of OTC Products Due to Possible Chemical Contamination - Updated |
10/20/2010 |
| Measles, Mumps, Rubella, and Varicella Vaccine (ProQuad) - Ongoing Safety Review |
03/04/2008 |
| Medicaid Tamper-Resistant Requirement - Delayed 6 Months |
9/28/2007 |
| Medroxyprogesterone acetate injection (Depo-Provera® Contraceptive Injection) associated with bone mineral density loss |
11/22/2004 |
| medroxyprogesterone acetate & estradiol cypionate injectable suspension (Lunelle™) |
10/14/2002 |
| mefloquine (Lariam®) |
10/04/2002 |
| meningococcal conjugate vaccine/Guillain Barre Syndrome associated with |
10/24/2006 |
| meningococcal polysaccharide vaccine |
12/15/2005 |
| METABOSLIM Dietary Supplement Contains Undeclared Sibutramine |
8/22/2007 |
| Methadone Hydrochloride (Dolophine, generics) - Cardiac and Respiratory Deaths |
11/28/2006 |
| Methotrexate Injection – New Safety Labeling Changes |
12/28/2011 |
| Methotrexate Injection Recalled - Potential Glass Particulates In Vials |
11/01/2010 |
| Methotrexate Injection From Bedford Recalled Due to Ethylene Glycol Content |
10/28/2002 |
| Methylene blue and Psychiatric Medication interactions - Update |
10/21/2011 |
| Methylphenidate Transdermal System (Daytrana™) Recall |
9/7/2007 |
| Methylphenidate hydrochloride 2.5 mg/5 mg/and 10 mg Chewable Tablets (Methylin CT) – Recall Update |
2/10/2005 |
| Metoclopramide (Reglan, generic) - Black Box Warning for Tardive Dyskinesia |
02/27/2009 |
| Metronidazole 250 mg Tablets by Teva - One Lot Recalled Due to Underweight Tablets |
01/07/2011 |
| Metronidazole Injection from Sagent Pharmaceuticals - Recall |
05/18/2010 |
| Micro-bubble Perflutren Contrast Agents (Definity and Optison) Associated with Deaths and Serious Cardiopulmonary Reactions - Update |
07/17/2008 |
| Midazolam Hydrochloride and Furosemide - Potential for Error |
08/10/2009 |
| Midodrine (ProAmatine, generic) Proposed Market Withdrawal - Update |
09/10/2010 |
| Mifepristone (Mifeprex/RU-486) associated with serious infection and bleeding - UPDATE |
3/20/2005 |
| Minocycline (Solodyn) - Two lots recalled due to product mix-up |
05/21/2008 |
| Miracle Mineral Solution (MMS) - Produces Harmful Chlorine Dioxide when Mixed as Directed with Citrus Juice |
08/02/2010 |
| Mislabeled Internet Medications - Dangerous Ingredients |
2/21/2007 |
| Mitoxantrone (Novantrone) - Cardiac Monitoring |
07/30/2008 |
| Mitoxantrone (Novantrone) - Cardiotoxicity and Secondary Acute Myelogenous Leukemia (AML) in Patients with Multiple Sclerosis |
5/25/2005 |
| Modafanil (Provigil) - Rash and Psychiatric Warnings |
10/25/2007 |
| Mommy's Bliss Nipple Cream - Harmful Ingredients for Nursing Babies |
05/30/2008 |
| Montelukast (Singulair) and Risk of Behavior Changes, Mood Changes, or Suicidality - Ongoing Safety Review |
06/12/2009 |
| Morphine Extended Release (Avinza) - Alcohol 5/cause dose-dumping |
11/4/2005 |
| Morphine Sulfate/Naltrexone HCl (Embeda®) - Voluntary Recall Due to Stability Concerns |
03/18/2011 |
| Morphine Sulfate Oral Solution - Reports of Accidental Overdose Due to Medication Use Error |
01/12/2011 |
| Morphine sulfate oral solutions |
10/10/2003 |
| Motrin® IB (Ibuprofen) Caplets and Tablets - Recall Due To Dissolution Problems |
12/23/2011 |
| Motrin/Children's chewable |
5/14/2004 |
| Multi-Mex Dietary Supplements - Recall Due To Misleading Names and Packaging |
05/12/2011 |
| Mycophenolate Mofetil (CellCept®) associated with Pure Red Cell Aplasia (PRCA) |
08/17/2009 |
| Mycophenolate products (Cellcept - mycophenolate mofetil, Myfortic - mycophenolic acid) - Medication Guide Now Required |
03/24/2009 |
| Mycophenolate Mofetil (Cellcept) and Mycophenolic Acid (Myfortic) and Birth Defect Risk |
05/16/2008 |
| Mycophenolate Mofetil (CellCept) and Mycophenolate Acid (Myfortic) and risk of Progressive Multifocal Leukoencephalopathy – Ongoing Safety Review |
06/30/2008 |
| Mycophenolate Products (Cellcept, Myfortic) - Pregnancy Risk Category Updated |
11/27/2007 |
| Mycophenolate Mofetil (Cellcept) Plus Sirolimus (Rapamune) - Increased Acute Rejection In Cardiac Transplant Patients |
2/26/2007 |
| Mycophenolic Acid (Myfortic®) - warning for risk of Pure Red Cell Aplasia (PRCA) |
09/09/2009 |
| Myozyme (Alglucosidase Alfa) - Formation of Black Particles During Reconstitution |
4/12/2007 |
| Nalbuphine (Nubain) - Use During Labor and Delivery |
1/10/2006 |
| Naltrexone Extended-Release Injectable Suspension (Vivitrol) - Injection Site Reactions and New Medication Guide Requirement UPDATE |
05/05/2010 |
| Naproxen (Aleve/Anaprox/Naprelan/Naprosyn) cardiovascular risk |
12/21/2004 |
| Natalizumab (Tysabri) Monotherapy and Progressive Multifocal Leukoencephalopathy |
01/23/2012 |
| Natalizumab (Tysabri) - Reports of Liver Injury after Natalizumab Use |
02/29/2008 |
| Natalizumab (Tysabri) - Resumed Marketing With a Special Restricted Distribution Program |
3/1/2005 |
| National Provider Identifier (NPI) - Personal Information Alert — UPDATED |
8/27/2007 |
| Nature Relief Instant Wart and Mole Remover - Recall Due to Risk of Serious Skin Burns |
06/29/2011 |
| NC Solution, and other Products by General Therapeutics Corp. Seized |
11/2/2007 |
| Nefazodone 50 mg/100 mg/150 mg/200 mg/and 250 mg Tablets Recall (Ivax Pharmaceuticals) |
3/31/2005 |
| Nelfinavir Mesylate (Viracept) - New Impurity Specifications |
9/14/2007 |
| NeoProfen (ibuprofen lysine) injection (Lundbeck) - Recall of Two Lots Due to Presence of Particulate Matter |
08/03/2010 |
| Nesiritide appropriate use/new guidelines for |
7/20/2005 |
| Nesiritide 5/adversely effect short-term survival and kidney function in patients with decompensated heart failure |
5/20/2005 |
| Neuraminidase Inhibitors, Oseltamivir Phosphate (Tamiflu) and Zanamivir (Relenza), Associated with Neuropsychiatric Events |
04/03/2008 |
| Nevirapine (Viramune®) - Risk factors for liver toxicity |
1/20/2005 |
| Nifedipine (Nifediac™ CC) Extended Release Tablets- Recall |
07/09/2008 |
| Nimodipine capsules warning: Do not give parenterally - Update |
8/2/2010 |
| NSAIDs and COX-2 Selective Inhibitors - Patient Medication Guide Requirement |
6/16/2005 |
| Non-Acetone Nail Polish Remover (Personal Care Products) - Recall, Potential for Chemical Burns) |
4/29/2009 |
| Norelgestromin/ethinyl estradiol patch (Ortho Evra) May Increase Blood Clot Risk |
9/21/2006 |
| norethindrone and ethinyl estradiol tablets (Nortrel) |
7/1/2003 |
| Norgestrel / Ethinyl Estradiol Tablets (Lo/Ovral®-28, generic) Recall – Potential for Wrong Tablet Count or Sequence |
02/01/2012 |
| Normal Saline Flush Recall (B. Braun) |
9/19/2007 |
| Novartis Recall of Several Over-the-Counter Medications |
01/10/2012 |
| NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection/[rDNA origin]) NovoLog (insulin aspart [rDNA origin] injection) - Change in Packaging to Help Prevent Dispensing Errors |
9/16/2005 |
| NuCel Labs “Eye Drops” and “Eye/Ear Wash” Recalled |
02/01/2008 |
| Nzu Dietary Supplements for Morning Sickness Contain Arsenic and Lead |
01/04/2010 |
| Octagam (Immune Globulin Intravenous 5% Liquid) Market Withdrawal - Update |
09/24/2010 |
| Olanzapine (Zyprexa, Zyprexa Zydis) - Use with Caution in Adolescents |
02/01/2010 |
| olanzapine/Name confusion with |
2/10/2005 |
| Olmesartan (Benicar®) and Increased Cardiovascular Events Ongoing Safety Review |
06/14/2010 |
| Omega-3-acid Ethyl Esters Brand Name Changed from Omacor to Lovaza |
8/16/2007 |
| Omacor (omega-3-acid ethyl esters) and Amicar (aminocaproic acid) Dispensing Errors |
3/2/2006 |
| Omalizumab (Xolair®) - Ongoing Safety Review Update |
07/16/2009 |
| Omalizumab (Xolair) - Reports of Delayed Anaphylaxis |
7/3/2007 |
| Omeprazole (Prilosec/Zegerid/generic) and Esomeprazole (Nexium) - Possible Association with Cardiac Events |
12/12/2007 |
| Ondansetron (Zofran) and Abnormal Heart Rhythms |
09/15/2011 |
| OneTouch® Blood Glucose Test Strips - Counterfeit Alert |
10/17/2006 |
| OneTouch® Test Strips |
1/30/2003 |
| Ondansetron (Zofran) |
2/3/2003 |
| Opiate and Opiate-Containing Mix-ups with Endo Medications |
01/09/2012 |
| Oral Bisphosphonates and Hip Fracture - Alendronate (Fosamax), Ibandronate (Boniva), Risedronate (Actonel), Zoledronic Acid (Reclast) - UPDATE |
10/14/2010 |
| Oral Colchicine (Colcrys) - Severe Drug Interactions with Strong CYP3A4 and P-glycoprotein Inhibitors |
08/03/2009 |
| Oral Osteoporosis Drugs (Bisphosphonates): Drug Safety Communication - Potential Increased Risk of Esophageal Cancer |
07/22/2011 |
| Orlaam® (levomethadyl hydrochloride acetate) |
9/10/2003 |
| Orlistat (Alli) -- Counterfeit Capsules |
01/26/2010 |
| Orlistat (Xenical and Alli) and Severe Liver Injury - UPDATE |
05/26/2010 |
| Orlistat (Xenical) - FDA Warning about Counterfeit Medications on the Internet |
5/3/2007 |
| Ortho Evra® (norelgestromin/ethinyl estradiol) Labeling Update |
01/23/2008 |
| Ortho Evra: higher estrogen exposure than oral contraceptives |
11/15/2005 |
| Oseltamivir (Tamiflu®) Oral Suspension- Labeling Change to Reflect New Concentration (6 mg/mL) |
07/13/2011 |
| Oseltamavir (Tamiflu) Counterfeit Products Sold on Internet |
06/18/2010 |
| Oseltamivir (Tamiflu) Oral Suspension-Potential for Dosing Errors |
09/29/2009 |
| Over-The-Counter Infants' and Children's Products - Voluntary Recall by McNeil Consumer Healthcare |
05/03/2010 |
| Over-The-Counter Camolyn Eye Drops And Fisiolin Nasal Drops - Recall For Possible Sterility Problems |
04/08/2010 |
| Oxcarbazepine (Trileptal) 5/cause serious skin and multiorgan hypersensitivity reactions |
4/25/2005 |
| Oxycodone 10 mg / Acetaminophen 325 mg Tablets (Endocet 10 mg / 325 mg) from Endo Recalled - Bottles May Contain Different Tablet Strengths |
06/27/2011 |
| Oxycodone Extended-Release Tablets From Endo, Dava, and Watson - Discontinued |
7/5/2007 |
| OxyContin (oxycodone extended-release) manufacturer pleads guilty to misbranding and misrepresenting product |
5/11/2007 |
| Oxymetazoline (Nostrilla®) Nasal Decongestant - Recall Due to Possible Bacterial Contamination |
10/24/2011 |
| Pai You Guo Dietary Supplement Contains Undeclared Sibutramine and Phenolphthalein |
11/13/2009 |
| Paliperidone palmitate (Invega Sustenna) - Recall Due to Cracks in Syringes |
02/17/2011 |
| Pamidronate and Zoledronic acid - reports of jaw osteonecrosis |
5/20/2005 |
Pancreatic Enzyme Products - New Products and Changes in Product Availability
Information for University of Utah Healthcare Employees
Information for the Public |
06/16/2010 |
| Pantoprazole (Protonix) I.V. glass vial breakage |
9/27/2004 |
| Paroxetine (Paxil®/Paxil CR®) Labeling Changes - Suicidality in Adults |
10/08/2009 |
| Patient Medication Guide Requirement - NSAIDs and COX-2 Selective Inhibitors |
6/16/2005 |
| Paxil and Paxil CR - updated Pregnancy Precautions |
12/8/2005 |
| PediaCare Children's Products from Blacksmith Brands - Recall |
06/01/2010 |
| Pediatric Injectable Drugs, 8th Edition (The Teddy Bear Book), Correction Notice - Typographical Errors in |
08/17/2009 |
| Pegaptanib Sodium Injection (Macugen): Labeling Changes Due to Reports of Anaphylaxis and Angioedema |
4/7/2006 |
| Pemoline Products Withdrawn from Market due to Risk of Liver Toxicity |
10/28/2005 |
| Penicillin G benzathine/Penicillin G procaine (Bicillin C-R) and Penicilln G benzathine (Bicillin L-A) - Inappropriate Use for Syphilis |
12/1/2004 |
| Pentrexyl Forte Natural Supplements - Recall Due To Misleading Packaging |
05/24/2011 |
| Peramivir Injection - Emergency Use Authorization for H1N1 Influenza |
12/01/2009 |
| pergolide mesylate (Permax) |
2/25/2003 |
| Pergolide Products Withdrawn From Market Due to Heart Valve Damage |
3/30/2007 |
| Perrigo Infant Drops containing Acetaminophen/Dextromethorphan/or Pseudoephedrine - Recall of |
8/4/2005 |
| PharmaFab to Stop Manufacturing Unapproved Drugs |
4/27/2007 |
| Phenytoin and Fosphenytoin - Skin Reactions More Common in Patients with the Human Leukocyte Antigen Allele, HLA*B 1502. |
11/25/2008 |
| Phosphocol P 32 - Increased Risk of Leukemia and Radiation Injury |
09/18/2008 |
| Pioglitazone (Actos): Ongoing Safety Review for Increased Risk of Bladder Cancer |
09/20/2010 |
| Pioglitazone (Actos) and Rosiglitazone (Avandia) - Stronger Warnings about Heart Failure |
8/15/2007 |
| Pioglitazone (Actos/Actoplus Met/Duetact) and Rosiglitazone (Avandia/Avandamet/Avandaryl) Increased Fracture Risk - Update |
3/9/2007 |
| Pimecrolimus (Elidel) and Tacrolimus (Protopic)/Potential Cancer Risk With Topical |
1/24/2006 |
| Potassium Iodide - Recommendations for Use After Radiation Exposure |
03/16/2011 |
| Potassium Phosphates Injection - Recall Due to Particulates, Filter Non-Recalled Lots - Update |
04/22/2011 |
| Povidone Iodine Prep Pads - Recall Due to Possible Microbial Contamination |
03/22/2011 |
| Pre-filled Glass Syringes - Compatibility Problems with Needless Intravenous Access Systems - UPDATE |
05/06/2011 |
| Premarin/Prempro/and Premphase |
2/16/2006 |
| Prevnar (Pneumococcal 7-valent Conjugate) Vaccine Recall |
7/20/2009 |
| Promethazine Hydrochloride Injection - Black Box Warning for Severe Tissue Injury |
09/17/2009 |
| Promethazine (Phenergan) injection classified as vesicant |
4/25/2005 |
| Promethazine and Fatal Respiratory Depression In Children Under Age 2 - Use Contraindicated |
2/18/2005 |
| Propafenone HCL 225 mg tablet recall by Watson |
03/25/2009 |
| Propofol (Hospira) - Recall of Additional Lots Due to Presence of Particulate Matter - UPDATE |
06/11/2010 |
| Propofol (Teva) - Recall of Two Lots Due to Presence of Endotoxin - UPDATE |
07/17/2009 |
| Propofol (Diprivan/generics) - Adverse Events Resembling Bacterial Sepsis |
6/19/2007 |
| Propoxyphene Products (Darvon, Darvocet) - Withdrawn From the Market |
11/19/2010 |
| Propylthiouracil (PTU) - Risk of Hepatotoxicity |
04/26/2010 |
| Proton Pump Inhibitors-Risk for Low Magnesium Levels with Prolonged Use |
03/02/2011 |
| Proton Pump Inhibitors (PPI) and Risk of Fracture: Class Labeling Change |
05/26/2010 |
| Povidone Iodine Products - Recall Due to Inadequate Microbial Testing |
08/29/2011 |
| Qualitest Pharmaceuticals Oral Contraceptives - Recall Due to Packaging Error |
09/19/2011 |
| Que She Dietary Supplement Contains Undeclared Sibutramine, Fenfluramine, Propranolol, and Ephedrine |
07/09/2010 |
| Quinine (Qualaquin) and Serious Hematologic Reactions |
07/09/2010 |
| Quinine Sulfate - FDA Orders Halt of the Sale of Unapproved Products |
12/13/2006 |
| Rabies Immune Globulin (HyperRAB S/D) - Uncalibrated Syringes |
02/25/2008 |
| Ranibizumab (Lucentis®) 0.5 mg Increases Stroke Risk - UPDATED |
2/1/2007 |
| Razadyne - brand name changed from Galantamine |
4/25/2005 |
| Recombinant Factor VIIa (NovoSeven) - Increased Risk of Arterial Thromboembolic Events |
12/2/2005 |
| Red Yeast Rice Supplements 5/Contain Lovastatin |
8/15/2007 |
| Remifentanil Hydrochloride (Ultiva) - Typographical Error in the Handbook on Injectable Drugs |
11/06/2009 |
| Rho(D) Immune Globulin Intravenous (Human) (WinRho SDF) Black Box Warning of Intravascular Hemolysis |
03/11/2010 |
| Rho(D) Immune Globulin Intravenous (WinRho) - Hematologic Safety Reports |
10/08/2009 |
| Rimantadine (Flumadine, generic) and Amantadine (Symmetrel, generic) - High Levels of Resistance By Influenza A H3N2 Viruses |
1/19/2006 |
| Risperidone and Risperdal® - Recall Due To Unusual Odor |
06/21/2011 |
| risperidone (Risperdal® - Janssen Pharmaceutical/Inc.) |
04/01/2003 |
| Risperidone (Risperdal) and Ropinirole (Requip) - Medication Errors Due to Name Confusion |
06/16/2011 |
| Rituximab (Rituxan®) and Progressive Multifocal Leukoencephalopathy (PML) |
10/26/2009 |
| Rituximab (Rituxan®) and Progressive Multifocal Leukoencephalopathy (PML) |
10/26/2009 |
| Rituximab (Rituxan) and Ibritumomab tiuxetan (Zevalin) - Potentially-fatal Skin and Mucus Membrane Reactions |
11/3/2005 |
| Rituximab and Hepatitis |
10/11/2004 |
| Rofecoxib (Vioxx®) withdrawn due to cardiovascular risk |
9/30/2004 |
| Rolaids Extra Strength Softchews, Rolaids Extra Strength Plus Gas Softchews, and Rolaids Multi-Symptom plus Anti-Gas Softchews Recalled - Foreign Materials in Product |
12/14/2010 |
| Romiplastim and Eltrombopag Risk Evaluation and Mitigation Strategy (REMS) Program |
12/09/2011 |
| Rosiglitazone (Avandia) and Pioglitazone (Actos) - Stronger Warnings about Heart Failure |
8/15/2007 |
| Rosiglitazone (Avandia) - Association with Ischemic Cardiovascular Events |
02/04/2011 |
| Rosiglitazone (Avandia/Avandamet/Avandaryl) 5/increase risk of fractures |
2/23/2007 |
| Rosiglitazone (Avandia, Avandamet, Avandaryl) - New Onset or Worsening Macular Edema |
1/12/2006 |
| Rosuvastatin (Crestor) - Myopathy and Rhabdomyolysis in Asian-Americans at 40 mg Dose |
3/3/2005 |
| Rotarix (Rotavirus Vacine, Live, Oral) - FDA Recommends Resuming Use |
05/18/2010 |
| Salagen (pilocarpine) and Selegiline (Eldepryl) Name Confusion |
03/03/2006 |
| Salivart Oral Moisturizer Recall |
3/7/2007 |
| Sanofi-Aventis Medications Stolen - Verify Drug Pedigrees |
07/27/2009 |
| Sanofi Pasteur Pediatric H1N1 Vaccine in Pre-filled Syringes - Non-Safety-Related Voluntary Recall |
12/24/2009 |
| Saquinavir (Invirase) and Ritonavir (Norvir): Potential Risk of Cardiac Arrhythmias - Update |
02/25/2010 |
| Saquinavir (Fortovase/Invirase) plus Ritonavir (ritonavir boosted saquinavir) interacts with rifampin - increased liver toxicity reported |
2/10/2005 |
| Sargramostim (Leukine) Liquid Formulation Withdrawn from Market; Special Access Program for Powder Formulation |
03/25/2008 |
| Schedule II Controlled Substances - Changes a Pharmacist May Make to Written Prescriptions - Utah Law Update |
05/24/2010 |
| Sedative-Hypnotic Labeling Revisions |
3/15/2007 |
| Selective Serotonin Reuptake Inhibitor (SSRI) Use During Pregnancy and the Risk of Persistent Pulmonary Hypertension of the Newborn (PPHN) – Update |
01/06/2012 |
| Selegiline (Eldepryl) and Salagen (pilocarpine) Name Confusion |
03/03/2006 |
| Seroquel (quetiapine) 25 mg tablet recall Lot 3446J |
5/5/2004 |
| Serotonin Syndrome With Triptans Plus SSRIs or SNRIs |
7/20/2006 |
| Sibutramine Hydrochloride (Meridia) Withdrawn from Market Due to Increased Risk of Cardiovascular Events |
10/11/2010 |
| Similac (Abbott) Powder Infant Formulas - Recall - UPDATE |
09/27/2010 |
| Simvastatin Products (Zocor, Vytorin, Simcor) and Muscle Injury: New Labeling Changes - Update |
12/16/2011 |
| Simvastatin/Ezetimibe (Vytorin) and Ezetimibe (Zetia) and Increased Risk for Cancer - Update of Safety Review |
12/24/2009 |
| Simvastatin products (Zocor, Zetia, Simcor, generic) and Amiodarone (Cordarone, Pacerone, generic) - Potentially Serious Interaction |
08/11/2008 |
| SimplyThick® - Necrotizing Enterocolitis in Premature Infants |
05/24/2011 |
| Sirolimus (Rapamune®) - Effect of Different Assays on Therapeutic Drug Monitoring |
01/13/2010 |
| Sirolimus (Rapamune®) - Safety in Liver Transplant Patients |
06/15/2009 |
| Sitagliptin (Januvia) and sitagliptin/metformin (Janumet) - Reports of Acute Pancreatitis |
09/29/2009 |
| Sodium Bicarbonate Injection - Recall Due to Particulates |
12/29/2010 |
| Sodium Chromate Cr-51 Injection Recall |
07/13/2009 |
| Sodium Phosphate (Oral) Products for Bowel Cleansing - Renal Adverse Effects |
12/12/2008 |
| Sodium Polystyrene Sulfonate - Recall Due to Contamination with Yeast |
07/17/2008 |
| Sodium Thiosulfate Injection - Recall Due to Particulates |
02/07/2011 |
| Soladek Vitamin Solution May Contain Toxic Amounts of Vitamins A and D |
03/29/2011 |
| SSRI Treatment During Pregnancy |
7/20/2006 |
| STARCAPS Diet System Capsules May Contain Bumetanide |
12/01/2008 |
| STDs: Unapproved and Misbranded Drugs for Prevention and Treatment of Marketed over the Internet |
03/07/2008 |
| Stealth Powdered Dietary Supplements - Recall due to possible Salmonella |
07/10/2009 |
| Sterile Lubricating Jelly - Recall Due to Potentially Unsterile Product |
02/17/2011 |
| Steroid Products Sold Illegally as Dietary Supplements |
3/14/2006 |
| Stimulant Medications for Attention-Deficit/Hyperactivity Disorder – Cardiovascular Safety Review in Adults |
12/14/2011 |
| Stimulant Medications for Attention-Deficit/Hyperactivity Disorder – Safety Review in Children and Young Adults – Update |
01/06/2012 |
| SureStep® Test Strips |
1/30/2003 |
| Tacrolimus (Protopic) and Pimecrolimus (Elidel)/Potential Cancer Risk With Topical |
1/24/2006 |
| Tamsulosin (Flomax) Associated with Intraoperative Floppy Iris Syndrome |
11/23/2005 |
| Tegaserod Maleate (Zelnorm®) |
4/28/2004 |
| Tegaserod (Zelnorm) - Discontinued, No Longer Available Through Treatment Investigational New Drug Protocol- UPDATE |
4/03/2008 |
| Telithromycin (Ketek) Updated Warnings - updated |
3/27/2007 |
| Terbutaline Injection and Tablets- New Contraindication for Prolonged Treatment of Preterm Labor |
02/22/2011 |
| Testosterone Gel Products and Inadvertent Exposure in Children |
05/08/2009 |
| Tiagabine (Gabitril) can cause seizures in patients without epilepsy | 2/23/2005 |
| Tigecycline (Tygacil) and Increased Mortality Risk |
09/02/2010 |
| Tigecycline (Tygacil®) Reformulation |
8/8/2007 |
| Tinzaparin - Increased Risk of Mortality - Ongoing Safety Analysis |
12/31/2008 |
| Tiotropium (Spiriva) and Risk of Stroke - Ongoing Safety Review |
10/08/2008 |
| Tiotropium Bromide (Spiriva) and Formoterol Fumarate (Foradil) Capsules, Correct Use of |
03/04/2008 |
| Tipranavir (Aptivus) Associated With Intracranial Hemorrhage |
7/6/2006 |
| Tizanidine (Zanaflex) - Contraindicated with Fluvoxamine or Ciprofloxacin |
4/12/2007 |
| Topical Anesthetic Agents for Medical and Cosmetic Procedures - Potentially Fatal Adverse Effects UPDATED |
01/20/2009 |
| Topical Hair Regrowth Products from Perfect Images Solutions - Recalled Due to Presence of Unapproved Drugs |
01/23/2012 |
| Topiramate (Topamax) 100 mg tablets - Recall Due to Musty Odor |
04/15/2011 |
| Topiramate (Topamax) - Use During Pregnancy May Increase Risk of Cleft Lip or Cleft Palate |
03/07/2011 |
| Toprol-XL (metoprolol succinate) extended release tablets name confusion |
9/28/2005 |
| “Total Body Formula” and “Total Body Mega Formula”- High Selenium Concentrations UPDATED |
04/10/2008 |
| Tramadol (Ultram, Ultracet) - Label Updates |
05/25/2010 |
| Tramadol injection - Typographical Error in the Handbook on Injectable Drugs |
01/05/2009 |
| Transdermal Patches with Metallic Backings - Risk of Burns if Worn During Magnetic Resonance Imaging Scans |
12/20/2010 |
| Trastuzumab (Herceptin) and Bacteriostatic Water for Injection Diluent Vials - Potential Vial Damage |
07/11/2008 |
| Trastuzumab (Herceptin) Increases Risk of Cardiotoxicity |
9/6/2005 |
| Trazodone interactions with CYP3A4 inhibitors & carbamazepine |
5/12/2004 |
| Triaminic Vapor Patch Voluntary Recall |
8/2/2006 |
| Trilipix® (Fenofibric Acid) - Labeling Changes Due to Inability to Lower Risk of Cardiovascular Events in the ACCORD Trial |
11/10/2011 |
| Trimethobenzamide Suppositories - Discontinued Due to Lack of Efficacy |
4/9/2007 |
| Tumor Necrosis Factor-alpha Blockers - Boxed Warnings Updated with Information on Legionella and Listeria Infection Risk |
09/08/2011 |
| Tumor Necrosis Factor (TNF) Blocking Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], golimimumab [Simponi], infliximab [Remicade])-Risk of Delayed Diagnosis of Opportunistic Infections |
06/30/2008 |
| Tumor Necrosis Factor (TNF) α Blocking Agents - Increased Risk of Lymphoma and Other Malignancies |
10/15/2004 |
| Tylenol® Extra Strength Caplets - Recall Due To Unusual Odor |
07/01/2011 |
| Ultane (sevoflurane) |
11/21/2003 |
| Ultram ER Voluntary Recall |
01/14/2009 |
| Utah Medicaid Preferred Drug List Update |
05/19/2009 |
| Vagifresh Ball, Vagifresh Gel, and Female One - Products Recalled |
01/23/2012 |
| Valdecoxib withdrawn/labeling changes for all NSAIDs/Adverse Effects of NSAIDs |
4/7/2005 |
| Valdecoxib (Bextra®) cardiovascular risk and severe skin reactions |
12/14/2004 |
| Valdecoxib (Bextra) |
11/13/2002 |
| Valganciclovir (Valcyte) - New Pediatric Dosing Recommendations |
09/16/2010 |
| Valproate Products and Risk of Impaired Cognitive Development in Children Due to Prenatal Exposure |
07/01/2011 |
| Valproic Acid Derivatives (valproate sodium [Depacon], valproic acid [Depakene, Stavzor], divalproex sodium [Depakote, Depakote CP, Depakote ER]) and Birth Defect Risk |
12/03/2009 |
| Varenicline (Chantix®) Safety Alert - Labeling Changes - UPDATE |
07/26/2011 |
| Vapor Patch Voluntary Recall - Triaminic Vapor Patch and WellPatch Cough & Cold Soothing Vapor Pads |
8/2/2006 |
| Varenicline (Chantix) - Neuropsychiatric Events and Suicidality Warnings added to the Prescribing Information - Update |
07/01/2009 |
| Vasopressin Injection USP, Multiple Dose Vials - Voluntary Recall Due to Potential for Reduced Potency |
08/04/2011 |
| Vasopressin injection - Typographical Error in the Handbook on Injectable Drugs |
12/08/2010 |
| Venlafaxine (Effexor®/Effexor XR®) - Overdose Risk |
10/30/2006 |
| Venom Hyperdrive dietary supplement contains undeclared sibutramine |
01/28/2009 |
| Vecuronium Bromide for Injection Recall by Hospira |
02/09/2009 |
| Vicks Sinex Nasal Spray - Recall of Specific Lots by Procter & Gamble |
11/20/2009 |
| Viramune (nevirapine) | 2/2/2004 |
| Vita Breath Dietary Supplement - May Contain Hazardous Lead Concentrations |
05/03/2010 |
| Vitamin D Supplements - Dosing Errors in Infants |
06/16/2010 |
| Warfarin 5 mg tablets - Voluntary Recall of a Single Lot of Coumadin 5 mg Tablets |
05/05/2011 |
| Warfarin (Coumadin) 1 mg Tablets in Blister Packs - Recall |
7/14/2010 |
| Warfarin - Pharmacogenomic Labeling Changes |
8/20/2007 |
| Warfarin Sodium (Coumadin®) - Patient Medication Guide and Black Box Warning |
10/11/2006 |
| Warfarin Sodium (Jantoven) 3 mg Tablets - Upsher-Smith Recall Expanded to Include Amantadine, Amlodipine, Baclofen, Bethanecol, Fluoxymesterone (Androxy), Oxybutynin, and Warfarin - Update |
02/24/2011 |
| Weight Loss Products Containing Undeclared Active Ingredients |
12/27/2010 |
| WellPatch Cough & Cold Soothing Vapor Pads Voluntary Recall |
8/2/2006 |
| Xenical (orlistat) - FDA Warning about Counterfeit Medications on the Internet |
5/3/2007 |
| Xigris 5/increase mortality in single organ dysfunction patients |
3/18/2005 |
| Zanaflex (Tizanidine) - Contraindicated with Fluvoxamine or Ciprofloxacin |
4/12/2007 |
| Zanamivir (Relenza) - Potentially Fatal if Nebulized |
10/9/09 |
| Zenapax (daclizumab) |
8/28/2003 |
| Zhen De Shou Dietary Supplement Contains Undeclared Sibutramine |
12/01/2008 |
| Ziagen (Abacavir Sulfate) and Combivir (Lamivudine/Zidovudine) - Third Party Tampering |
4/12/2007 |
| Zicam Cold Remedy Nasal Products Associated with Loss of Sense of Smell |
06/16/2009 |
| Ziprasidone and fluoroquinolones. |
12/2003 |
| Zoledronic Acid Contraindicated in Patients with Renal Dysfunction |
09/02/2011 |
| Zonisamide (Zonegran® and Generics) - Risk of Metabolic Acidosis |
02/23/2009 |
| Zyprexa/Name confusion with |
2/10/2005 |
| Zyrtec/Name confusion with |
2/10/2005 |
| Zyvox (linezolid) and Psychiatric Medications Interaction - UPDATE |
10/21/2011 |
